These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20686966)

  • 21. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL; Li JL; Vitetta ES
    J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
    Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
    Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus.
    Wiczling P; Rosenzweig M; Vaickus L; Jusko WJ
    J Clin Pharmacol; 2010 May; 50(5):494-506. PubMed ID: 19934031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma.
    Frankel AE; Woo JH; Ahn C; Foss FM; Duvic M; Neville PH; Neville DM
    Haematologica; 2015 Jun; 100(6):794-800. PubMed ID: 25795722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin.
    Wang Z; Duran-Struuck R; Crepeau R; Matar A; Hanekamp I; Srinivasan S; Neville DM; Sachs DH; Huang CA
    Bioconjug Chem; 2011 Oct; 22(10):2014-20. PubMed ID: 21866954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous protein.
    Hexham JM; King V; Dudas D; Graff P; Mahnke M; Wang YK; Goetschy JF; Plattner D; Zurini M; Bitsch F; Lake P; Digan ME
    Biotechnol Appl Biochem; 2001 Dec; 34(3):183-7. PubMed ID: 11730486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system.
    Hayden MS; Linsley PS; Gayle MA; Bajorath J; Brady WA; Norris NA; Fell HP; Ledbetter JA; Gilliland LK
    Ther Immunol; 1994 Jan; 1(1):3-15. PubMed ID: 7584477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry.
    Colombatti M; Greenfield L; Youle RJ
    J Biol Chem; 1986 Mar; 261(7):3030-5. PubMed ID: 3485093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
    Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J
    J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
    Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
    Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9.
    Huang CA; Yamada K; Murphy MC; Shimizu A; Colvin RB; Neville DM; Sachs DH
    Transplantation; 1999 Sep; 68(6):855-60. PubMed ID: 10515387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin.
    Chaudhary VK; Gallo MG; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9491-4. PubMed ID: 2251289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression, purification and specific monoclonal antibodies preparation of diphtheria toxin A fragment].
    Ouyang J; Wang JW; Wang CX; Guo L; Tuo HZ; Cui T; Hong T
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):689-93. PubMed ID: 15973991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Fluorouracil enhances apoptosis sensitivity of T lymphocytes mediated by CD3 epsilon.
    Cheng H; Liu Y; Liu S; Zheng D
    Cell Biochem Funct; 2004; 22(3):187-95. PubMed ID: 15124184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
    Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
    Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
    Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
    Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective killing of T cells by immunotoxins directed at distinct V beta epitopes of the T cell receptor.
    Rigaut KD; Scharff JE; Neville DM
    Eur J Immunol; 1995 Jul; 25(7):2077-82. PubMed ID: 7542605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.